Initial Disclosure Notice – Teresa Farac-Ciprian

Initial Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Rua Bioscience Limited
Date this disclosure made:
15-Dec-23
Date on which issuer listed or appointment made:
1-Aug-22
Director or senior manager giving disclosure
Full name:
Teresa Farac-Ciprian
Name of listed issuer:
Rua Bioscience Limited
Name of related body corporate (if applicable):
n/a
Position held in listed issuer:
Director
Summary of relevant interest (excluding specified derivatives)
Class of quoted financial product: Ordinary Shares
Number held in class:100,000
Nature of relevant interest: Beneficial holder
Current registered holder: Teresa Farac-Ciprian
Summary of specified derivatives relevant interest (if applicable)
Type of derivative: n/a
Class of underlying financial products:n/a
Details of derivative
The notional value of the derivative (if any) or the notional amount of underlying
products (if any):
n/a
A statement as to whether the derivative is cash settled or physically settled:n/a
Maturity date of the derivative (if any):n/a
Expiry date of the derivative (if any):n/a
The price specified in the terms of the derivative(if any):n/a
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
n/a
For that derivative,-
Parties to the derivative:n/a
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
n/a
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of person authorised to sign on behalf of director or officer:
Date of signature:15-Dec-23
Name and title of authorised person:Paul Naske - Chief Executive Officer